Award

Pagliarini chanced into groundbreaking mitochondrial research

He won the ASBMB's 2020/2021 Earl and Thressa Stadtman Young Scholar Award
Gelareh (Abulwerdi)  Vinueza
Nov. 1, 2019

Dave Pagliarini’s research career had a bumpy start. By his third year of graduate school, he had followed his advisers to three labs across the Midwest and West Coast. He finished his Ph.D. in biomolecular sciences at the University of California, San Diego. Pagliarini learned a lot from each adviser, he said, and “those challenges became my accelerators.”

Those accelerators have propelled him through almost a decade of productive mitochondria research, for which Pagliarini will receive the American Society for Biochemistry and Molecular Biology’s 2020/2021 Earl and Thressa Stadtman Young Scholar Award.

Morgridge Institute for Research
Dave Pagliarini

Pagliarini got into mitochondria research by chance when, as a grad student, he identified a new mitochondrial phosphatase that plays a critical role in biosynthesis of the essential cardiolipin required for optimal mitochondrial bioenergetics. This discovery led him to look for other mitochondrial proteins with unknown functions that could play a role in mitochondrial diseases.

Mitochondrial diseases affect one in every 4,000 individuals; uncharacterized mitochondrial proteins contribute to diseases such as mitochondrial encephalomyopathy, a neurodegenerative disorder for which there are no curative treatments.

During his postdoc in Vamsi Mootha’s laboratory at Harvard, Pagliarini established a compendium of more than 1,000 mitochondrial proteins by combining in-depth computational biology and biochemistry. He called it MitoCarta and published his findings in the journal Cell. Although this approach at first provided only a descriptive dataset, what set Pagliarini apart from others in his field was “his ability … to gain understanding of underlying cellular, biochemical, and physiological processes and mechanisms,” Christopher Newgard wrote in a letter supporting the award nomination.

Pagliarini is now the lead investigator and Arthur C. Nielsen chair of metabolism at the Morgridge Institute for Research. His lab works to discover additional orphan mitochondrial proteins and characterize them from molecular to organ level.

MitoCarta: the key to unlock mitochondrial diseases

Dave PagliariniAs a postdoc, Dave Pagliarini led the development of MitoCarta, a compendium providing an extensive map of mitochondrial proteins. Since then, his lab has become known for using systematic lipidomics, proteomics and metabolomics screens to study the effects of the loss of individual mitochondrial proteins and then digging into those proteins’ biochemical activities. One example is the team’s analysis of the biosynthetic pathway that generates coenzyme Q.

Coenzyme Q, or CoQ, a lipid member of the mitochondrial electron transport chain remarkable for its redox activity, was discovered in the late 1950s just down the street from Pagliarini’s laboratory in Madison, Wisconsin. Although this unusual lipid is involved in myriad mitochondrial diseases, its biosynthesis and transport are not completely understood, which makes understanding the associated diseases difficult.

Mapping the CoQ synthesis pathway led Pagliarini’s lab to discover the functions of multiple orphan proteins. One is CoQ9, a lipid chaperone that binds to CoQ intermediates and is essential for its biosynthesis. Another is CoQ8A, an atypical kinase/ATPase essential for the assembly of the CoQ biosynthetic complex. Each of these proteins has been shown to play a role in mitochondrial diseases.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Gelareh (Abulwerdi)  Vinueza

Gelareh (Abulwerdi) Vinueza graduated with her Ph.D. from the molecular medicine program at the University of Maryland, Baltimore. She is currently a policy fellow at the Food and Drug Administration. She has been an ASBMB volunteer writer since 2018 and is passionate about science communication and science policy. Outside of work, she enjoys photography, hiking and cooking.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Building a stronger future for research funding
Interview

Building a stronger future for research funding

Jan. 9, 2026

Hear from Eric Gascho of the Coalition for Health Funding about federal public health investments, the value of collaboration and how scientists can help shape the future of research funding.

Fueling healthier aging, connecting metabolism stress and time
Feature

Fueling healthier aging, connecting metabolism stress and time

Jan. 8, 2026

Biochemist Melanie McReynolds investigates how metabolism and stress shape the aging process. Her research on NAD+, a molecule central to cellular energy, reveals how maintaining its balance could promote healthier, longer lives.

Mapping proteins, one side chain at a time
Award

Mapping proteins, one side chain at a time

Jan. 7, 2026

Roland Dunbrack Jr. will receive the ASBMB DeLano Award for Computational Biosciences at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.

2026 voter guide
Society News

2026 voter guide

Jan. 6, 2026

Learn about the candidates running for Treasurer-elect, Councilor and Nominating Committee.

Meet the editor-in-chief of ASBMB’s new journal, IBMB
Profile

Meet the editor-in-chief of ASBMB’s new journal, IBMB

Jan. 5, 2026

Benjamin Garcia will head ASBMB’s new journal, Insights in Biochemistry and Molecular Biology, which will launch in early 2026.

Exploring the link between lipids and longevity
Profile

Exploring the link between lipids and longevity

Jan. 2, 2026

Meng Wang will present her work on metabolism and aging at the ASBMB Annual Meeting, March 7-10, just outside of Washington, D.C.